|
US2019153096A1
|
|
Cd3/cd33 bispecific binding molecules
|
|
US2019100587A1
|
|
IgG1 Fc MUTANTS WITH ABLATED EFFECTOR FUNCTIONS
|
|
US2018280527A1
|
|
FGFR3 binding molecules
|
|
AU2014256037A1
|
|
Novel bispecific binding molecules with antitumoral activity
|
|
MX2014011066A
|
|
Novel binding molecules with antitumoral activity.
|
|
EP2752426A1
|
|
Human serum albumin binding compounds and fusion proteins thereof
|
|
EP2711016A1
|
|
Novel IL-17A binding molecules and medical uses thereof
|
|
EP2638916A1
|
|
Novel binding molecules with antitumoral activity
|
|
EP2597102A1
|
|
A novel fusion protein comprising an antibody light chain and a polypeptide binding to IL-17
|
|
EP2524927A1
|
|
New chymase binding compounds and medical uses thereof
|
|
EP2470556A1
|
|
Il-17 binding compounds and medical uses thereof
|
